Cagrilintide
Cagrilintide (AM833, NNC0174-0833)
Long-acting synthetic amylin analogue for weight management and type 2 diabetes. Works as a dual amylin and calcitonin receptor agonist (DACRA), mimicking natural amylin hormone to regulate appetite, slow gastric emptying, and promote satiety.
Complete Dosing Guide
Who Should Not Take Cagrilintide & Safety Tips
Do Not Take If:
- You have a personal or family history of medullary thyroid carcinoma
- You have Multiple Endocrine Neoplasia syndrome type 2
- You're allergic to cagrilintide or any components
- You have severe gastroparesis
Use Carefully If:
- You have a history of pancreatitis
- You have gallbladder disease
- You have severe gastrointestinal disease
- You're taking other medications that slow gastric emptying
Who Should Not Take Cagrilintide & Safety Tips
Do Not Take If:
- You have a personal or family history of medullary thyroid carcinoma
- You have Multiple Endocrine Neoplasia syndrome type 2
- You're allergic to cagrilintide or any components
- You have severe gastroparesis
Use Carefully If:
- You have a history of pancreatitis
- You have gallbladder disease
- You have severe gastrointestinal disease
- You're taking other medications that slow gastric emptying
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.